Bvf Inc Foghorn Therapeutics Inc. Put Options Transaction History
Bvf Inc
- $3.27 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding FHTX
# of Institutions
73Shares Held
32.7MCall Options Held
6KPut Options Held
1.8K-
Flagship Pioneering Inc. Cambridge, MA12.7MShares$115 Million8.71% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.52MShares$22.9 Million0.3% of portfolio
-
Raymond James & Associates St Petersburg, FL2.3MShares$20.9 Million0.01% of portfolio
-
Euclidean Capital LLC New York, NY1.57MShares$14.3 Million1.14% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$14.1 Million0.0% of portfolio
About Foghorn Therapeutics Inc.
- Ticker FHTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,637,400
- Market Cap $379M
- Description
- Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...